NewEdge Advisors, LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1633516 NEW ORLEANS, LA

Position in ARWR

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$105,963

+$22,572 QoQ

Shares Held

1,300

-2.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#398

of 497 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

NewEdge Advisors, LLC holds $47,755,733 across 102 Biotechnology names. ARWR ranks #41 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	18,435	$9,157,217
2	REGN	Regeneron Pharmaceuticals, Inc.	11,911	$7,426,984
3	NUVB	Nuvation Bio Inc.	1,231,733	$6,996,243
4	INCY	Incyte Corp	34,605	$3,922,822
5	PHAT	Phathom Pharmaceuticals, Inc.	203,962	$2,212,987
6	EXEL	Exelixis, Inc.	32,532	$1,770,066
7	BMRN	Biomarin Pharmaceutical Inc	27,287	$1,561,362
8	RPRX	Royalty Pharma plc	21,597	$1,210,943

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$105,963	1,300	-2.3%	Shares	Sole	2026-08-12
2026-03-31	$83,391	1,330	+2.3%	Shares	Sole	2026-06-03
2025-12-31	$86,307	1,300	0.0%	Shares	Sole	2026-02-18
2025-09-30	$44,837	1,300	0.0%	Shares	Sole	2025-11-17
2025-06-30	$20,540	1,300	-0.1%	Shares	Sole	2025-08-14
2025-03-31	$16,574	1,301	0.0%	Shares	Sole	2025-05-15
2024-12-31	$24,458	1,301	+23.8%	Shares	Sole	2025-02-13
2024-09-30	$20,357	1,051	0.0%	Shares	Sole	2024-11-14
2024-06-30	$27,315	1,051	-3.8%	Shares	Sole	2024-08-16
2024-03-31	$31,259	1,093	-39.0%	Shares	Sole	2024-05-14
2023-12-31	$54,865	1,793	0.0%	Shares	Sole	2024-02-13
2023-09-30	$48,177	1,793	+24.3%	Shares	Sole	2023-11-14
2023-06-30	$51,457	1,443	0.0%	Shares	Sole	2023-08-14
2023-03-31	$36,652	1,443	-43.3%	Shares	Sole	2023-05-12
2022-12-31	$103,144	2,543	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.